Testing effectiveness (Phase 2)Study completedNCT01849250
What this trial is testing
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
Who this might be right for
Benign Breast NeoplasmDuctal Breast Carcinoma In SituInvasive Breast Carcinoma+9 more
National Cancer Institute (NCI) 65